HDAC3 and Alzheimer disease: HHT prevented AD from increasing expression levels of HDAC3 and MCP1 (Figure S2A), regulating expression levels of inducible Nitric oxide synthase (iNOS) and CD163 (Figure S2A), inducing epidermal hyperplasia (Figure S2B) and increasing number of activated mast cells (Figure S2B).